A new cancer jab has produced strong responses in patients with advanced head and neck cancer in the United Kingdom, offering hope to people whose disease had stopped responding to existing treatments.
A proposed programme could help reduce mosquito-borne diseases in the United States by releasing sterilised male mosquitoes to suppress populations of the invasive Aedes aegypti species.
A genomic test could help many people with breast cancer avoid chemotherapy while achieving the same outcomes, marking a major advance in personalised treatment in the United Kingdom.
A new philanthropic fund is investing USD 140 million to accelerate the development of vaccines against Strep A, a disease responsible for hundreds of thousands of deaths each year worldwide.
In Burkina Faso, malaria cases and deaths have dropped sharply following the rollout of a new vaccine, offering families renewed protection against one of the country’s most persistent diseases.
In Algeria, trachoma—the world’s leading infectious cause of blindness—has been eliminated as a public health problem after decades of sustained national effort.
England is introducing a new injectable cancer immunotherapy that delivers treatment in minutes, improving patient experience while freeing up hospital capacity.
South Africa’s HPV vaccination programme has cut infections of the most dangerous virus types by more than 80% in teenage girls, marking a major step toward preventing cervical cancer in a high-risk population.
A personalised immune cell therapy has successfully treated three life-threatening autoimmune diseases in a single patient, offering new hope for tackling complex immune disorders.
Spain has successfully kept a human uterus alive outside the body for 24 hours, opening new possibilities for studying fertility, pregnancy and uterine diseases.
